Company intelligence / Profile preview

Theravant Sciences

Livermore, California, United States

Ownership: Private
Employees: ~25
Development stage: Other

Overview

Theravant developed the TheraClear Acne System, an FDA-cleared, commercial-stage acne treatment device that uses vacuum and broadband light to target multiple forms of acne and redness. The device is used in over 20 countries, with clinical adoption driven by visible and rapid improvement in acne symptoms.

Therapeutic areas: Dermatology
Modalities: Device
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Theravant Sciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Theravant Sciences.

Explore the full profile